Parcourir par titre
Voici les éléments 2425-2444 de 13742
-
Chroniques génomique : Programmes génome : une overdose de commentaires ?
(John Libbey Eurotext, Montrouge, 1991) -
Chroniques génomiques
(John Libbey Eurotext, Montrouge, 1990) -
Chroniques génomiques - 23andMe et le mal des transports
(Éditions EDK, Groupe EDP Sciences, 2016)A Genome Wide Association Study on propensity to motion sickness published by 23andMe gives interesting results, shows validity for self-reported phenotypic information and underlines the value of the model developed by ... -
Chroniques génomiques - 23andMe ou comment (très bien) valoriser ses clients
(Éditions EDK, Groupe EDP Sciences, 2015)The announcement of several deals between the DTC genetics firm 23andMe and Genentech, Pfizer and other corporations reveals the real business model of the company: selling access to sets of characterized patients for ... -
Chroniques génomiques - Actualités du séquençage d’ADN
(EDP Sciences, 2019)The planned acquisition of Pacific Biosciences by Illumina could signal a big change in the DNA sequencing landscape, and provides the incentive for an update on a field that still has a number of players and could be ... -
Chroniques génomiques - AlphaFold : un pas essentiel vers la fonction des protéines
(EDP Sciences, 2021) -
Chroniques génomiques - Balayage du génome et repérage des personnes à risque : Des GWAS aux GPS
(EDP Sciences, 2018)The accumulation of extensive repositories linking phenotypic and genetic information, together with new computation methods, makes it possible to derive polygenic scores for susceptibility to common diseases that turn out ... -
Chroniques génomiques - Biopsies liquides, une révolution en cancérologie ?
(Éditions EDK, Groupe EDP Sciences, 2015)The detection and analysis of circulating tumour DNA and/or circulating tumour cells in the blood of cancer patients open new possibilities for cancer characterisation and management. The approach has generated much ... -
Chroniques génomiques - Cancer : les trois époques de la médecine personnalisée :
(Éditions EDK, Groupe EDP Sciences, 2017)Since the completion of the first human DNA sequence, genomic approaches have penetrated into cancer research and therapy: first through expression profiling for diagnostic, prognostic and predictive purposes, then by ... -
Chroniques génomiques - Cancer :faut-il viser la lune ?
(Éditions EDK, Groupe EDP Sciences, 2016)The recently announced “Cancer moonshot” may be greeted with scepticism: the previous “War on cancer” (1971) was not very successful. However the current plan seems well targeted, with emphasis not only on research investment ...